Novel insights into changes in biochemical properties of keratins 8 and 18 in griseofulvin-induced toxic liver injury

Experimental and Molecular Pathology

Volumn 89, Issue 2, 2010, Pages 117-125

  Fortier, Anne Marie ^a   Riopel, Kathleen ^a   Désaulniers, Martin ^a   Cadrin, Monique ^a  

^a UNIVERSITÉ DU QUÉBEC À TROIS RIVIÈRES   (Canada)

Author keywords

Hepatitis; Hepatocyte; Intermediate filaments; Keratins; Liver; Mallory Denk Bodies; Toxic stress

Indexed keywords

CYTOKERATIN 18; CYTOKERATIN 8; GRISEOFULVIN; MITOGEN ACTIVATED PROTEIN KINASE P38;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; IN VIVO STUDY; INTERMEDIATE FILAMENT; LIVER CELL; LIVER TOXICITY; MOUSE; NONHUMAN; PHYSICAL CHEMISTRY; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; ANIMAL; C3H MOUSE; CHEMISTRY; GENETICS; LIVER; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; SOLUBILITY; TOXIC HEPATITIS;

ANIMALS; DRUG-INDUCED LIVER INJURY; GRISEOFULVIN; HEPATOCYTES; KERATIN-18; KERATIN-8; LIVER; MICE; MICE, INBRED C3H; PHOSPHORYLATION; SOLUBILITY;

ANIMALIA; MUS; MUS MUSCULUS;

EID: 77956446100     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2010.07.004     Document Type: Article

References (68)

1. Albers K.M., et al. Expression of an epidermal keratin protein in liver of transgenic mice causes structural and functional abnormalities. J. Cell Biol. 1995, 128:157-169.
2. Amidi F., et al. M-30 and 4HNE are sequestered in different aggresomes in the same hepatocytes. Exp. Mol. Pathol. 2007, 83:296-300.
3. Bardag-Gorce F., et al. The role of the ubiquitin-proteasome pathway in the formation of mallory bodies. Exp. Mol. Pathol. 2002, 73:75-83.
4. Bardag-Gorce F., et al. The cyclic pattern of blood alcohol levels during continuous ethanol feeding in rats. The effect of feeding S-adenosylmethionine. Exp. Mol. Pathol. 2010, 88:352-362.
5. Bardag-Gorce F., et al. SAMe prevents the induction of the immunoproteasome and preserves the 26S proteasome in the DDC-induced MDB mouse model. Exp. Mol. Pathol. 2010, 65:376-379.
6. Boller K., et al. Differential distribution of cytokeratins after microinjection of anti-cytokeratin monoclonal antibodies. Eur. J. Cell Biol. 1987, 43:459-468.
7. Cadrin M., et al. Mallory bodies in hepatomas and hyperplastic nodules: in vitro and in vivo studies. Prog. Clin. Biol. Res. 1990, 331:231-248.
8. Cadrin M., et al. Modifications in cytokeratin and actin in cultured liver cells derived from griseofulvin-fed mice. Lab Invest. 1995, 72:453-460.
9. Cadrin M., et al. Griseofulvin hepatotoxicity-related effects in keratin 8 deficient FVB/N mice. Mol. Biol. Cell 1996, 6S:2171.
10. Cadrin M., et al. Early perturbations in keratin and actin gene expression and fibrillar organisation in griseofulvin-fed mouse liver. J. Hepatol. 2000, 33:199-207.
11. Caulin C., et al. Caspase cleavage of keratin 18 and reorganization of intermediate filaments during epithelial cell apoptosis. J. Cell Biol. 1997, 138:1379-1394.
12. Chou C.F., Omary M.B. Mitotic arrest-associated enhancement of O-linked glycosylation and phosphorylation of human keratins 8 and 18. J. Biol. Chem. 1993, 268:4465-4472.
13. Chou C.F., et al. A significant soluble keratin fraction in 'simple' epithelial cells. Lack of an apparent phosphorylation and glycosylation role in keratin solubility. J. Cell Sci. 1993, 105(Pt 2):433-444.
14. Cochrane, G. R., Galperin, M.Y., 2010. The 2010 Nucleic Acids Research Database Issue and online Database Collection: a community of data resources. Nucleic Acids Res. 38, D1-4.
15. Coulombe P.A., Omary M.B. 'Hard' and 'soft' principles defining the structure, function and regulation of keratin intermediate filaments. Curr. Opin. Cell Biol. 2002, 14:110-122.
16. Coulombe P.A., et al. A function for keratins and a common thread among different types of epidermolysis bullosa simplex diseases. J. Cell Biol. 1991, 115:1661-1674.
17. Denk H., et al. Hepatocellar hyalin (Mallory bodies) in long term griseofulvin-treated mice: a new experimental model for the study of hyalin formation. Lab Invest. 1975, 32:773-776.
18. Eriksson J.E., et al. Specific in vivo phosphorylation sites determine the assembly dynamics of vimentin intermediate filaments. J. Cell Sci. 2004, 117:919-932.
19. Fausther M., et al. Heat shock protein 70 expression, keratin phosphorylation and Mallory body formation in hepatocytes from griseofulvin-intoxicated mice. Comp Hepatol. 2004, 3:5.
20. Fickert P., et al. Mallory body formation in primary biliary cirrhosis is associated with increased amounts and abnormal phosphorylation and ubiquitination of cytokeratins. J. Hepatol. 2003, 38:387-394.
21. Fortier A.M., et al. Akt isoforms regulate intermediate filament protein levels in epithelial carcinoma cells. FEBS Lett. 2010, 584:984-988.
22. French S.W. Mallory bodies revisited. Arch. Pathol. Lab. Med. 1979, 103:204.
23. Fuchs E., Weber K. Intermediate filaments: structure, dynamics, function, and disease. Annu. Rev. Biochem. 1994, 63:345-382.
24. Hattori K., et al. The roles of ASK family proteins in stress responses and diseases. Cell Commun Signal. 2009, 7:9.
25. He T., et al. The intermediate filament protein keratin 8 is a novel cytoplasmic substrate for c-Jun N-terminal kinase. J. Biol. Chem. 2002, 277:10767-10774.
26. Herrmann H., Aebi U. Intermediate filaments: molecular structure, assembly mechanism, and integration into functionally distinct intracellular Scaffolds. Annu. Rev. Biochem. 2004, 73:749-789.
27. Herrmann H., et al. Functional complexity of intermediate filament cytoskeletons: from structure to assembly to gene ablation. Int. Rev. Cytol. 2003, 223:83-175.
28. Hyder C.L., et al. Providing cellular signposts-post-translational modifications of intermediate filaments. FEBS Lett. 2008, 582:2140-2148.
29. Krebs E.G. The growth of research on protein phosphorylation. Trends Biochem. Sci. 1994, 19:439.
30. Ku N.O., Omary M.B. Phosphorylation of human keratin 8 in vivo at conserved head domain serine 23 and at epidermal growth factor-stimulated tail domain serine 431. J. Biol. Chem. 1997, 272:7556-7564.
31. Ku N.O., Omary M.B. A disease- and phosphorylation-related nonmechanical function for keratin 8. J. Cell Biol. 2006, 174:115-125.
32. Ku N.O., et al. Chronic hepatitis, hepatocyte fragility, and increased soluble phosphoglycokeratins in transgenic mice expressing a keratin 18 conserved arginine mutant. J. Cell Biol. 1995, 131:1303-1314.
33. Ku N.O., et al. Susceptibility to hepatotoxicity in transgenic mice that express a dominant-negative human keratin 18 mutant. J. Clin. Invest. 1996, 98:1034-1046.
34. Ku N.O., et al. Apoptosis generates stable fragments of human type I keratins. J. Biol. Chem. 1997, 272:33197-33203.
35. Ku N.O., et al. Mutation of a major keratin phosphorylation site predisposes to hepatotoxic injury in transgenic mice. J. Cell Biol. 1998, 143:2023-2032.
36. Ku N.O., et al. Keratin 8 mutations in patients with cryptogenic liver disease. N Engl J. Med. 2001, 344:1580-1587.
37. Ku N.O., et al. Keratin 8 phosphorylation by p38 kinase regulates cellular keratin filament reorganization: modulation by a keratin 1-like disease causing mutation. J. Biol. Chem. 2002, 277:10775-10782.
38. Ku N.O., et al. Keratin binding to 14-3-3 proteins modulates keratin filaments and hepatocyte mitotic progression. Proc. Natl Acad. Sci. U. S. A. 2002, 99:4373-4378.
39. Ku N.O., et al. Keratin 8 and 18 mutations are risk factors for developing liver disease of multiple etiologies. Proc. Natl Acad. Sci. U. S. A. 2003, 100:6063-6068.
40. Ku N.O., et al. Keratin mutation in transgenic mice predisposes to Fas but not TNF-induced apoptosis and massive liver injury. Hepatology 2003, 37:1006-1014.
41. Lazarides E. Intermediate filaments as mechanical integrators of cellular space. Nature 1980, 283:249-256.
42. Liao J., Omary M.B. 14-3-3 proteins associate with phosphorylated simple epithelial keratins during cell cycle progression and act as a solubility cofactor. J. Cell Biol. 1996, 133:345-357.
43. Liao J., et al. Stress, apoptosis, and mitosis induce phosphorylation of human keratin 8 at Ser-73 in tissues and cultured cells. J. Biol. Chem. 1997, 272:17565-17573.
44. Loranger A., et al. Simple epithelium keratins are required for maintenance of hepatocyte integrity. Am. J. Pathol. 1997, 151:1673-1683.
45. Mikhailov A., et al. The G2 p38-mediated stress-activated checkpoint pathway becomes attenuated in transformed cells. Curr. Biol. 2007, 17:2162-2168.
46. Moll R., et al. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 1982, 31:11-24.
47. Nan L., et al. Mallory body (cytokeratin aggresomes) formation is prevented in vitro by p38 inhibitor. Exp. Mol. Pathol. 2006, 80:228-240.
48. Olsen J.V., et al. Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell 2006, 127:635-648.
49. Omary M.B., et al. Keratin modifications and solubility properties in epithelial cells and in vitro. Subcell. Biochem. 1998, 31:105-140.
50. Omary M.B., et al. 'Heads and tails' of intermediate filament phosphorylation: multiple sites and functional insights. Trends Biochem. Sci. 2006, 31:383-394.
51. Schutte B., et al. Keratin 8/18 breakdown and reorganization during apoptosis. Exp. Cell Res. 2004, 297:11-26.
52. Sivaramakrishnan S., et al. Micromechanical properties of keratin intermediate filament networks. Proc. Natl Acad. Sci. U. S. A. 2008, 105:889-894.
53. Sivaramakrishnan S., et al. Shear stress induced reorganization of the keratin intermediate filament network requires phosphorylation by protein kinase C zeta. Mol. Biol. Cell 2009, 20:2755-2765.
54. Strnad P., et al. Denaturing temperature selection may underestimate keratin mutation detection by DHPLC. Hum. Mutat. 2006, 27:444-452.
55. Strnad P., et al. Keratin variants associate with progression of fibrosis during chronic hepatitis C infection. Hepatology 2006, 43:1354-1363.
56. Stumptner C., et al. Hepatocyte cytokeratins are hyperphosphorylated at multiple sites in human alcoholic hepatitis and in a mallory body mouse model. Am. J. Pathol. 2000, 156:77-90.
57. Stumptner C., et al. Sequence of events in the assembly of Mallory body components in mouse liver: clues to the pathogenesis and significance of Mallory body formation. J. Hepatol. 2001, 34:665-675.
58. Stumptner C., et al. Sequence of events in the assembly of Mallory body components in mouse liver: clues to the pathogenesis and significance of Mallory body formation. J. Hepatol. 2001, 34:665-675.
59. Thornton T.M., Rincon M. Non-classical p38 map kinase functions: cell cycle checkpoints and survival. Int. J. Biol. Sci. 2009, 5:44-51.
60. Toivola D.M., et al. Keratin 8 and 18 hyperphosphorylation is a marker of progression of human liver disease. Hepatology 2004, 40:459-466.
61. Woll S., et al. p38 MAPK-dependent shaping of the keratin cytoskeleton in cultured cells. J. Cell Biol. 2007, 177:795-807.
62. Wood C.D., et al. Nuclear localization of p38 MAPK in response to DNA damage. Int. J. Biol. Sci. 2009, 5:428-437.
63. Yuan Q.X., et al. Mechanisms of mallory body formation induced by okadaic acid in drug-primed mice. Exp. Mol. Pathol. 1998, 65:87-103.
64. Zatloukal K., et al. Cytokeratin 8 protects from hepatotoxicity, and its ratio to cytokeratin 18 determines the ability of hepatocytes to form Mallory bodies. Am. J. Pathol. 2000, 156:1263-1274.
65. Zatloukal K., et al. From Mallory to Mallory-Denk bodies: what how and why?. Exp. Cell Res. 2007, 313:2033-2049.
66. Zhong B., et al. Organ-specific stress induces mouse pancreatic keratin overexpression in association with NF-kappaB activation. J. Cell Sci. 2004, 117:1709-1719.
67. Zhou Q., et al. Keratin mutation primes mouse liver to oxidative injury. Hepatology 2005, 41:517-525.
68. Zhou Q., et al. Keratin 20 serine 13 phosphorylation is a stress and intestinal goblet cell marker. J. Biol. Chem. 2006, 281:16453-16461.